Inhibrx Biosciences, Inc. (INBX)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Inhibrx Biosciences, Inc.’s filings yet. We add companies and filings all the time.
Track INBX and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| MORGAN STANLEY | Aug 13, 2026 | $123.94M |
| VIKING GLOBAL INVESTORS LP | Aug 14, 2026 | $106.49M |
| BANK OF AMERICA CORP /DE/ | Aug 14, 2026 | $79.7M |
| BlackRock, Inc. | Aug 7, 2026 | $78.26M |
| STATE STREET CORPORATION | Sep 22, 2026 | $60.68M |
INBX's filings are public. The insight is one click away.
Scrutar's AI reads every INBX filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a INBX filing.
Get an email when INBX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.